2-(클로로메틸)-1-메틸-1H-이미다졸염화물

2-(chloromethyl)-1-methyl-1H-imidazole hydrochloride

HCID 2795406

노트 반응

부분 구조 검색 유사 구조 찾기

기본 정보

CAS: 78667-04-6
표준 SMILES: Cl.Cn1ccnc1CCl
InChIKey: JDIPKQBKSBWIKU-UHFFFAOYSA-N
분자식: C5H8Cl2N2
평균 분자량: 167.03 g/mol
단동위원소 질량: 166.00645362

이름 및 식별자

우선 이름: 2-(chloromethyl)-1-methyl-1H-imidazole hydrochloride
IUPAC: 2-(chloromethyl)-1-methylimidazole;hydrochloride
현지명: 2-(클로로메틸)-1-메틸-1H-이미다졸염화물
영어명: 2-(CHLOROMETHYL)-1-METHYL-1H-IMIDAZOLE HYDROCHLORIDE
분자식: C5H8Cl2N2
분자량: 167.04

이름 및 동의어

2-(chloromethyl)-1-methyl-1H-imidazole hydrochloride78667-04-6DTXSID30383656RefChem:253487DTXCID50334680640-792-0MFCD002341182-(chloromethyl)-1-methylimidazole;hydrochloride2-chloromethyl-1-methyl-1H-imidazole hydrochloride2-(chloromethyl)-1-methylimidazole hydrochloride1H-Imidazole, 2-(chloromethyl)-1-methyl-, monohydrochloride2-Chloromethyl-1-methyl-1H-imidazole HCl

이름 더 보기

2-(클로로메틸)-1-메틸-1H-이미다졸염화물2-Chloromethyl-1-methyl-1H-imida1-Methyl-2-(chloromethyl)imidazole hydrochloride2-(Chloromethyl)-1-methyl-1H-imidazole hydrochloride 95%1H-IMidazole,2-(chloroMethyl)-1-Methyl-, hydrochloride (1:1)

SCHEMBL3119542-(chloromethyl)-1-methyl-1h-imidazolehydrochlorideJDIPKQBKSBWIKU-UHFFFAOYSA-NSBB0880452-(chloromethyl)-1-methyl-1h-imidaAKOS008044401AC-28879BP-10783

데이터베이스 식별자

CAS: 78667-04-6
PubChem CID: 2795406
DTXSID: DTXSID30383656
EC Number: 640-792-0

물성

구조 계산 물성

극성 표면적: 17.8 Å²
수소 결합 공여자 수: 1
수소 결합 수용자 수: 1
회전 가능 결합 수: 1
무거운 원자 수: 9
형식 전하: 0
복잡도: 76.8

물리화학적 성질

녹는점: 175 °C · 175 °C
저장 조건: 2 · under inert gas (nitrogen or Argon) at 2-8°C
물리적 상태: 가루
색상: 베이지색

안전 및 규제

GHS 분류

GHS Classification · 4건

Danger

H302 (40%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P264, P264+P265, P270, P280, P301+P317, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 5 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.